FHIR IG analytics| Package | us.nlm.vsac |
| Resource Type | ValueSet |
| Id | ValueSet-2.16.840.1.113762.1.4.1078.581.json |
| FHIR Version | R4 |
| Source | https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1078.581/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.581 |
| Version | 20230829 |
| Status | active |
| Date | 2023-08-29T01:01:27-04:00 |
| Name | PIM_Avandamet |
| Title | PIM_Avandamet |
| Realm | us |
| Authority | hl7 |
| Description | Need to change name to generic since combo drug? |
| Purpose | (Clinical Focus: Medications containing metformin and rosiglitazone in different strengths),(Data Element Scope: DRUG_CLASS_MEMBERS: PHARMACOLOGIC:),(Inclusion Criteria: Includes multi-ingredient medications.),(Exclusion Criteria: Single ingredient) |
No resources found
| CodeSystem | |
| rxnorm | RxNorm |
No narrative content found in resource
{
"resourceType": "ValueSet",
"id": "2.16.840.1.113762.1.4.1078.581",
"meta": {
"versionId": "6",
"lastUpdated": "2023-12-21T17:43:03.000-05:00",
"profile": [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail": {
"name": "Optum Author"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate": "2024-01-19"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate": "2023-08-29"
}
],
"url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.581",
"identifier": [
{
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113762.1.4.1078.581"
}
],
"version": "20230829",
"name": "PIM_Avandamet",
"title": "PIM_Avandamet",
"status": "active",
"date": "2023-08-29T01:01:27-04:00",
"publisher": "Optum Steward",
"description": "Need to change name to generic since combo drug?",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "US"
}
]
}
],
"purpose": "(Clinical Focus: Medications containing metformin and rosiglitazone in different strengths),(Data Element Scope: DRUG_CLASS_MEMBERS: PHARMACOLOGIC:),(Inclusion Criteria: Includes multi-ingredient medications.),(Exclusion Criteria: Single ingredient)",
"compose": {
"include": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"concept": [
{
"code": "1175016",
"display": "Avandamet Oral Product"
},
{
"code": "1175021",
"display": "Avandamet Pill"
},
{
"code": "352450",
"display": "Avandamet"
},
{
"code": "806287",
"display": "metformin / rosiglitazone Oral Tablet [Avandamet]"
},
{
"code": "861761",
"display": "metformin hydrochloride 1000 MG / rosiglitazone 2 MG [Avandamet]"
},
{
"code": "861762",
"display": "metformin hydrochloride 1000 MG / rosiglitazone 2 MG Oral Tablet [Avandamet]"
},
{
"code": "861807",
"display": "metformin hydrochloride 500 MG / rosiglitazone 2 MG [Avandamet]"
},
{
"code": "861808",
"display": "metformin hydrochloride 500 MG / rosiglitazone 2 MG Oral Tablet [Avandamet]"
},
{
"code": "861818",
"display": "metformin hydrochloride 500 MG / rosiglitazone 4 MG Oral Tablet [Avandamet]"
}
]
}
]
},
"expansion": {
"identifier": "urn:uuid:7069c23c-4cc0-4a50-8049-5057dcce5969",
"timestamp": "2025-05-23T17:51:55-04:00",
"total": 0
}
}